JOSHUA TATUM: Open Payments
NPI 1225566540 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 7 payments from 5 companies in 2025. Trend: 2023 $50 · 2024 $0 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $271 |
| TOLMAR, INC. | 1 | $139 |
| Astellas Pharma US Inc | 1 | $98 |
| Gilead Sciences, Inc. | 1 | $41 |
| UROGEN PHARMA, INC. | 1 | $29 |
Products named: RYBREVANT, Xtandi, Yeztugo.
Industry payments across WI — which companies pay providers there.
